- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Minimal Residual Disease monitoring
Total 386253 results
-
Bellicum PharmaceuticalsActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Ziopharm OncologyCompletedAcute Lymphoblastic Leukemia | Non-Hodgkin Lymphoma | Minimal Residual Disease | Small Lymphocytic Lymphoma | Acute Biphenotypic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia | CD19 Positive | Blasts 5 Percent or More of Bone Marrow Nucleated CellsUnited States
-
National Cancer Institute (NCI)CompletedLeukemia, Lymphoblastic, Acute | ALL, ChildhoodUnited States
-
University Hospital, Basel, Switzerlandpropatient foundation BaselCompleted
-
Bristol-Myers SquibbWithdrawnNon-Small Cell Lung Cancer | Non-Small-Cell Lung Carcinoma | Circulating Tumor DNA
-
Sumithira VasuCompletedRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes | Recurrent Adult Acute Myeloid Leukemia | Recurrent Childhood Acute Myeloid Leukemia | Minimal Residual DiseaseUnited States
-
Istanbul UniversityCompletedGeneral Anesthesia | Inhalation; GasTurkey
-
University of British ColumbiaAmgenTerminatedMinimal Residual Disease | B-cell Adult Acute Lymphoblastic Leukemia | Stem Cell LeukemiaCanada
-
AIDS Clinical Trials GroupNational Institute of Allergy and Infectious Diseases (NIAID)CompletedLiver Diseases | Hepatitis C | HIV-1-infectionUnited States, Uganda, Brazil, Puerto Rico, South Africa, Thailand
-
National Cancer Institute (NCI)TerminatedMelanoma | Sarcoma | Thoracic Sarcomas | Thorasic Cancers | Cancers of Non-thoracic Origin With Metastases to the Lungs or PleuraUnited States
-
University of JenaLudwig-Maximilians - University of MunichTerminatedAcute Myeloid Leukemia, AdultGermany
-
Gruppo Italiano Malattie EMatologiche dell'AdultoActive, not recruitingAcute Lymphoid Leukemia | Philadelphia Chromosome-Negative B-Cell PrecursorItaly
-
Therapeutic Advances in Childhood Leukemia ConsortiumGenzyme, a Sanofi CompanyTerminatedMinimal Residual Disease | Leukemia, Lymphoblastic, Acute | Leukemia, Myelogenous, AcuteUnited States
-
Boston Medical CenterCompleted
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedSecondary | De Novo | Untreated Philadelphia Positive Acute Lymphoblastic Leukemia | Low-dose Corticosteroids PretreatmentItaly
-
University Hospital, GhentCompleted
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...Active, not recruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic/Myeloproliferative Neoplasm | Minimal Residual Disease | Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable | Acute Myeloid Leukemia in RemissionUnited States
-
Merus N.V.Active, not recruitingAcute Myeloid Leukemia | Acute Myelogenous LeukemiaUnited States, Italy, Netherlands, Belgium, France
-
Astellas Pharma Global Development, Inc.Approved for marketingAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsUnited States, Canada, Japan
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)WithdrawnAcute Myeloid Leukemia | Minimal Residual Disease NegativityUnited States
-
Centre Hospitalier Universitaire de BesanconUniversity Hospital, Rouen; Central Hospital, Nancy, France; University Hospital... and other collaboratorsCompletedMinimal Residual Disease | Neoplastic Pathology | Cryopreserved Ovarian TissueFrance
-
UNC Lineberger Comprehensive Cancer CenterCompletedAcute Myeloid LeukemiaUnited States
-
Karolinska InstitutetFudan University; University Medical Center GroningenCompletedTuberculosis, Multidrug ResistantChina
-
AmgenTerminatedHigh-risk Diffuse Large B-cell LymphomaUnited States, Italy, Belgium, Switzerland, Australia, France, Greece
-
Chinese PLA General HospitalUnknownAcute Myeloid Leukemia, in Relapsed or Refractory | Acute Myeloid Leukemia, Elderly, Unfit | Acute Myeloid Leukemia With Positive Minimal Residual DiseaseChina
-
Tufts Medical CenterCompletedMinimal Residual Disease as a Possible Predictive Factor for Relapse in Patients With AL AmyloidosisAmyloidosis | Primary AmyloidosisUnited States
-
University of WashingtonNational Cancer Institute (NCI)TerminatedB Acute Lymphoblastic Leukemia | Recurrent Acute Lymphoblastic Leukemia | Minimal Residual Disease | T Acute Lymphoblastic LeukemiaUnited States
-
Shanghai iCELL Biotechnology Co., Ltd, Shanghai...Hebei Yanda Ludaopei HospitalUnknownAcute Myeloid LeukemiaChina
-
Peking University People's HospitalUnknownAcute Leukemia | Allogeneic Hematopoietic Stem Cell Transplantation | Minimal Residual Disease | Relapse | Donor Lymphocyte Infusion | Graft-versus-host DiseaseChina
-
M.D. Anderson Cancer CenterCelgene CorporationCompletedLeukemiaUnited States
-
Nanfang Hospital of Southern Medical UniversityPeking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaboratorsCompletedAcute Myeloid Leukemia | Minimal Residual DiseaseChina
-
Nanfang Hospital of Southern Medical UniversityPeking University People's Hospital; Guangzhou First People's Hospital; Sun Yat-Sen... and other collaboratorsCompletedHematopoietic Stem Cell Transplantation | Minimal Residual Disease | Relapse | Donor Lymphocyte InfusionChina
-
Amgen Research (Munich) GmbHCompletedB-cell Acute Lymphoblastic LeukemiaAustria, Belgium, France, Germany, Italy, Netherlands, Poland, Romania, Russian Federation, Spain, United Kingdom
-
University of FloridaCelgene CorporationTerminatedMyelodysplastic Syndromes | Leukemia, MyeloidUnited States
-
Centre Hospitalier Universitaire de BesanconUniversity Hospital, Rouen; CHU de Reims; Central Hospital, Nancy, France; University... and other collaboratorsCompletedNeoplastic Pathology | Autopreserved Ovarian TissueFrance
-
Sellas Life Sciences GroupUnknownMultiple Myeloma | Minimal Residual Disease | High-Risk CancerUnited States
-
Novartis PharmaceuticalsWithdrawnLeukemia, Myeloid, Acute
-
National Cancer Institute (NCI)CompletedNon-Metastatic Ewings SarcomaUnited States
-
University Hospital, MontpellierHospices Civils de Lyon; Centre Hospitalier Universitaire de Nice; Centre Hospitalier... and other collaboratorsUnknown
-
Shanghai Changzheng HospitalUnknown
-
Jakob Louis ThomsenMerck Sharp & Dohme LLCCompletedNeuromuscular BlockadeDenmark
-
Vanderbilt University Medical CenterCompletedMuscle WeaknessUnited States
-
Shanghai Zhongshan HospitalUnknown
-
University of CagliariUniversity of Turin, Italy; University Hospital, Udine, Italy; Azienda Sanitaria... and other collaboratorsUnknownArthritis, Psoriatic | Ultrasonography | Minimal Disease, ResidualItaly
-
The Institute of Molecular and Translational Medicine...Brno University Hospital; Tomas Bata Hospital, Czech RepublicCompletedColon Cancer | Minimal Residual DiseaseCzechia
-
Memorial Sloan Kettering Cancer CenterPfizerWithdrawnAcute Myeloid Leukemia (AML) | Minimal Residual DiseaseUnited States
-
Guy's and St Thomas' NHS Foundation TrustUnknownHearing Loss, CochlearUnited Kingdom
-
Nanfang Hospital of Southern Medical UniversityGuangzhou First People's Hospital; Second Affiliated Hospital, Sun Yat-Sen... and other collaboratorsUnknownAcute Myeloid Leukemia | Minimal Residual Disease | Granulocyte Colony-stimulating FactorChina
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
Nanfang Hospital of Southern Medical UniversityUnknownMinimal Residual Disease,Acute Leukemia, Hypomethylating Agents, Donor Lymphocyte Infusion, Allogeneic Hematopoietic Cell TransplantationChina